Fundraising Fox

Aspira Women's Health

OTC: AWHL

Austin, US · Delaware corporation

aspirawh.com
BiotechHealthtech

Founders & leadership

SM
Sandra MilliganPresident
NS
Nicole SandfordChief Executive Officer and Interim Chief Financial Officer
RB
Robert BeecheyExecutive
VB
Valerie B. PalmieriExecutive

Board

WP
Winfred ParnellBoard director
SC
Stefanie CavanaughBoard director
CF
Celeste FralickBoard director
EO
Ellen O'Connor VosBoard director
JH
Jannie HerchukBoard director
VG
Veronica G. H. JordanBoard director
JT
James T. LaFranceBoard director
JS
James S. BurnsBoard director

Reported raises · per SEC filings

Form D private placements

$25.2M disclosed across 6 rounds · 2020–2026

$1.5MraisedJun 2026 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • WINFRED PARNELLDirector
  • JEFFREY COHENDirector
  • ELLEN BEAUSANGDirector
  • CYNTHIA HUNDORFEANDirector
  • JOHN STRAHLEYExecutive Officer
  • JOHN FRASERExecutive Officer, Director
  • Jane PINE WOODDirector
Offering amount
$1.5M
Amount sold
$1.5M
First sale
Jun 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3MraisedSep 2025 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • ELLEN BEAUSANGDirector
  • MICHAEL BUHLEExecutive Officer
  • Jane PINE WOODDirector
  • JACK FRASERDirector
  • BRIAN HUNGERFORDExecutive Officer
  • CYNTHIA HUNDORFEANDirector
  • JEFFREY COHENDirector
  • WINFRED PARNELLDirector
Offering amount
$3M
Amount sold
$3M
First sale
Sep 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.4MraisedMar 2025 · 27 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • ELLEN BEAUSANGDirector
  • WINFRED PARNELLDirector
  • MICHAEL BUHLEExecutive Officer
  • JOHN RAGARDDirector
  • JANNIE HERCHUKDirector
  • CELESTE FRALICKDirector
  • JAMES CRAWFORDExecutive Officer
  • ELLEN O'CONNOR-VOSDirector
  • STEFANIE CAVANAUGHDirector
Offering amount
$1.4M
Amount sold
$1.4M
First sale
Mar 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.9MraisedJul 2024 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Winfred ParnellDirector
  • Stefanie CavanaughDirector
  • Celeste FralickDirector
  • Sandra MilliganExecutive Officer
  • Ellen O'Connor VosDirector
  • Nicole SandfordExecutive Officer, Director
  • Jannie HerchukDirector
Offering amount
$1.9M
Amount sold
$1.9M
First sale
Jun 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$6.5MraisedFeb 2024 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Minh MerchantExecutive Officer
  • Lynn O'Connor VosDirector
  • Nicole SandfordExecutive Officer, Director
  • Stefanie CavanaughDirector
  • Winfred ParnellDirector
  • Jannie HerchukDirector
  • Celeste FralickDirector
  • Torsten HombeckExecutive Officer
  • Jody BerryExecutive Officer
Offering amount
$6.5M
Amount sold
$6.5M
First sale
Jan 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$11MraisedJul 2020 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Veronica G. H. JordanDirector
  • James T. LaFranceDirector
  • James S. BurnsDirector
  • Robert BeecheyExecutive Officer
  • David R. SchreiberDirector
  • Nancy G. CocozzaDirector
  • Valerie B. PalmieriExecutive Officer, Director
Offering amount
$11M
Amount sold
$11M
Minimum investment
$150K
First sale
Jul 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap
Labcorp24 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Quest Diagnostics20 shared keywordsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.
Cancerresearchuk17 shared keywordsCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.
American Cancer Society (ACS)16 shared keywordsThe American Cancer Society is a nonprofit cancer-fighting organization that combats cancer through advocacy, research, and patient support. It provides information, guidance, caregiver resources, screening guidance, and clinical trial navigation for cancer patients, families, and caregivers, and funds cancer research.
MD Anderson Cancer Center14 shared keywordsUT MD Anderson is a cancer hospital providing cancer treatment, prevention, clinical care, and research, including new therapies and clinical trials for cancer patients. It is ranked among the top hospitals in the U.S. for cancer care.

Companies competing with Aspira Women's Health for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

How much funding has Aspira Women's Health raised?
Aspira Women's Health has disclosed $25.2M raised across 6 rounds.
Where is Aspira Women's Health headquartered?
Aspira Women's Health is headquartered in Austin, US.